{"id":4740,"date":"2025-10-07T12:35:42","date_gmt":"2025-10-07T09:35:42","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=4740"},"modified":"2025-11-03T20:18:48","modified_gmt":"2025-11-03T17:18:48","slug":"new-data-presented-on-duvyzat-givinostat-for-treatment-of-duchenne-muscular-dystrophy-at-2025-world-muscle-society-congress","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/zh\/new-data-presented-on-duvyzat-givinostat-for-treatment-of-duchenne-muscular-dystrophy-at-2025-world-muscle-society-congress\/","title":{"rendered":"2025\u5e74\u4e16\u754c\u808c\u8089\u534f\u4f1a\u5927\u4f1a\u4e0a\u516c\u5e03Duvyzat\uff08Givinostat\uff09\u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u7684\u65b0\u6570\u636e"},"content":{"rendered":"

Italfarmaco \u5ba3\u5e03\uff0c\u5c06\u5728 10 \u6708 7 \u65e5\u81f3 11 \u65e5\u4e8e\u5965\u5730\u5229\u7ef4\u4e5f\u7eb3\u4e3e\u884c\u7684\u7b2c 30 \u5c4a\u4e16\u754c\u808c\u8089\u534f\u4f1a (WMS) \u56fd\u9645\u5927\u4f1a\u4e0a\u516c\u5e03\u6709\u5173 givinostat \u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7 (DMD) \u7684\u66f4\u591a\u6570\u636e\u3002<\/strong> \u6d77\u62a5\u5c55\u793a\u91cd\u70b9\u4ecb\u7ecd\u4e86 givinostat \u5bf9 DMD \u60a3\u8005\u7684\u957f\u671f\u5b89\u5168\u6027\uff0c\u63a2\u7d22\u4e86\u5173\u952e EPIDYS \u7814\u7a76\u7684\u4e8b\u540e\u5206\u6790\u4e2d\u6309\u5e74\u9f84\u5212\u5206\u7684\u7597\u6548\uff0c\u5e76\u63d0\u4f9b\u4e86\u5728\u8be5 3 \u671f\u7814\u7a76\u4e2d\u89c2\u5bdf\u5230\u7684\u80c3\u80a0\u9053\u4e0d\u826f\u4e8b\u4ef6\u7684\u8be6\u7ec6\u63cf\u8ff0\u3002< Duvyzat (Givinostat) \u662f\u4ec0\u4e48\uff1f<\/a> >><\/p>\n\n\n\n

\u8fd9\u4e9b\u7531 Italfarmaco \u8d5e\u52a9\u7684\u7814\u7a76\u6570\u636e\u5728 2025 \u5e74 WMS \u5927\u4f1a\u4e0a\u516c\u5e03\uff0c\u5305\u62ec\uff1a<\/p>\n\n\n\n

651P Givinostat \u5bf9\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u60a3\u8005\u7684\u957f\u671f\u5b89\u5168\u6027\uff1a\u4e00\u9879\u5f00\u653e\u6807\u7b7e\u6269\u5c55\u7814\u7a76\u7684\u7ed3\u679c<\/strong><\/p>\n\n\n\n

\u6b63\u5728\u8fdb\u884c\u7684Givinostat\u6cbb\u7597DMD\u7537\u5b69\u7684\u957f\u671f\u7814\u7a76\uff0c\u6301\u7eed\u4e3a\u8be5\u6cbb\u7597\u7684\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u63d0\u4f9b\u65b0\u7684\u89c1\u89e3\uff0c\u5176\u7ed3\u679c\u4e0e\u4e4b\u524d\u7684\u77ed\u671f\u7814\u7a76\u4e00\u81f4\u3002\u4e00\u4e9b\u60a3\u8005\u76ee\u524d\u5df2\u670d\u7528Givinostat\u8d85\u8fc78\u5e74\uff0c\u6db5\u76d6\u4e86\u591a\u9879\u7814\u7a76\u548c\u6269\u5c55\u9636\u6bb5\u3002<\/p>\n\n\n\n

684VP \u5409\u7ef4\u8bfa\u53f8\u4ed6\u6309\u5e74\u9f84\uff086-7\u5c81\u548c>7\u5c81\uff09\u7684\u7597\u6548\uff1aEPIDYS \u7684\u4e00\u9879\u4e8b\u540e\u5206\u6790<\/strong><\/p>\n\n\n\n

\u7814\u7a76\u4e2d\u57fa\u7ebf\u8bc4\u4f30\u4e3a\u4e0d\u540c\u5e74\u9f84\u6bb5\u60a3\u6709 DMD \u7684\u7537\u5b69\u7684\u8eab\u4f53\u673a\u80fd\u63d0\u4f9b\u4e86\u91cd\u8981\u89c1\u89e3\u3002<\/p>\n\n\n\n

688VP \u63cf\u8ff0 Givinostat \u6cbb\u7597\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u60a3\u8005\u7684 3 \u671f\u4e34\u5e8a\u8bd5\u9a8c\u4e2d\u503c\u5f97\u5173\u6ce8\u7684\u80c3\u80a0\u9053\u4e0d\u826f\u4e8b\u4ef6<\/strong><\/p>\n\n\n\n

\u8be5\u7814\u7a76\u6301\u7eed\u76d1\u6d4b\u53d7\u8bd5\u8005\u7684\u80c3\u80a0\u9053\u4e8b\u4ef6\uff0c\u5927\u591a\u6570\u62a5\u544a\u7684\u4e8b\u4ef6\u4e25\u91cd\u7a0b\u5ea6\u4e3a\u8f7b\u5ea6\u81f3\u4e2d\u5ea6\uff0c\u65e0\u9700\u505c\u836f\u5373\u53ef\u7f13\u89e3\u3002\u8fd9\u4e9b\u53d1\u73b0\u4e3a\u7406\u89e3\u957f\u671f\u6cbb\u7597\u7684\u6574\u4f53\u5b89\u5168\u6027\u548c\u8010\u53d7\u6027\u63d0\u4f9b\u4e86\u91cd\u8981\u4fe1\u606f\u3002<\/p>\n\n\n\n

\u9605\u8bfb\u66f4\u591a<\/strong>:\u00a0\u675c\u6c0f\u808c\u8425\u517b\u4e0d\u826f\u75c7\u4e34\u5e8a\u8bd5\u9a8c\uff08\u6240\u6709\u7814\u7a76\u5217\u8868\uff09<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Italfarmaco announced that additional data on givinostat for the treatment of Duchenne muscular dystrophy (DMD) are being presented at the 30th annual International Congress of the World Muscle Society (WMS) held October 7-11 in Vienna, Austria. Poster presentations highlight the long-term safety of givinostat in patients with DMD, explore efficacy by age in a post […]<\/p>\n","protected":false},"author":1,"featured_media":4741,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[46,47,311],"class_list":["post-4740","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-duvyzat","tag-givinostat","tag-italfarmaco"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/4740","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/comments?post=4740"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/posts\/4740\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media\/4741"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/media?parent=4740"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/categories?post=4740"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/zh\/wp-json\/wp\/v2\/tags?post=4740"}],"curies":[{"name":"\u53ef\u6e7f\u6027\u7c89\u5242","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}